The Compound Operational Lead (COL) is a global leadership role responsible for providing strategic direction, operational oversight, and end-to-end execution leadership across clinical development programs. Working in close partnership with cross-functional stakeholders, the COL leads operational strategy from First-in-Human (FIH) through regulatory submission and commercialization, ensuring efficient, patient-centric, and high-quality delivery of global clinical programs.
The COL serves as the primary Clinical Operations representative at the program level, driving alignment across functions, managing program complexity, and ensuring delivery against timelines, budgets, quality standards, and corporate objectives. This role requires strong leadership, program management expertise, and the ability to influence decision-making across senior stakeholders and governance bodies.
Candidates will typically have prior experience in roles such as:
This position offers the opportunity to provide strategic leadership across the full lifecycle of clinical development programs and directly influence the successful delivery of innovative therapies to patients worldwide.
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. Learn more at https://jobs.iqvia.com
IQVIA is committed to integrity in our hiring process and maintains a zero tolerance policy for candidate fraud. All information and credentials submitted in your application must be truthful and complete. Any false statements, misrepresentations, or material omissions during the recruitment process will result in immediate disqualification of your application, or termination of employment if discovered later, in accordance with applicable law. We appreciate your honesty and professionalism.

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.